Literature DB >> 35756742

Kidney-placenta crosstalk in health and disease.

Omar Cabarcas-Barbosa1, Olivia Capalbo2, Alberta Ferrero-Fernández2, Carlos G Musso2.   

Abstract

Organ crosstalk allows the interaction between systems to adapt to a constant changing environment, maintaining homeostasis. The process of placentation and the new hormonal environment during pregnancy trigger physiological changes that modulate kidney function to control extracellular volume, acid-base balance and filtration of metabolic waste products. The bidirectional communication means that acute or chronic dysfunction of one organ can compromise the other. Abnormal placentation in pregnancy-related hypertensive disorders such as pre-eclampsia and HELLP (haemolysis, elevated liver enzymes and low platelet count) syndrome leads to the release of antiangiogenic factors that may cause kidney injury (thrombotic microangiopathy, glomeruloendotheliosis, mesangiolysis and vasoconstriction of peritubular vessels). These hypertensive disorders are a key cause of kidney injury in gestation, which increases maternal morbimortality and adverse foetal outcomes. Conversely, prior kidney injury or causes of kidney injury (diabetes, lupus, glomerulonephritis or other forms of chronic kidney disease) increase the risk of developing hypertensive pregnancy disorders, providing a baseline higher risk. Inherited kidney diseases are a special concern, given the potential for genetic predisposition to kidney disease in the foetus. Understanding the bidirectional potential for compromise from placenta to kidney and vice versa provides a better framework to limit damage to both organs and improve maternal and foetal outcomes.
© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.

Entities:  

Keywords:  HELLP syndrome; crosstalk; eclampsia; kidney; placenta

Year:  2022        PMID: 35756742      PMCID: PMC9217636          DOI: 10.1093/ckj/sfac060

Source DB:  PubMed          Journal:  Clin Kidney J        ISSN: 2048-8505


  46 in total

1.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Placental inflammation by HMGB1 activation of TLR4 at the syncytium.

Authors:  Line H Tangerås; Gabriela B Silva; Guro S Stødle; Lobke M Gierman; Bente Skei; Karin Collett; Anne-Lise Beversmark; Ragnhild B Skråstad; Liv Cecilie V Thomsen; Line Bjørge; Ann-Charlotte Iversen
Journal:  Placenta       Date:  2018-11-02       Impact factor: 3.481

Review 3.  Acute Kidney Injury in Pregnancy.

Authors:  Belinda Jim; Vesna D Garovic
Journal:  Semin Nephrol       Date:  2017-07       Impact factor: 5.299

4.  ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

Review 5.  Renal Disorders in Pregnancy: Core Curriculum 2019.

Authors:  Maria L Gonzalez Suarez; Andrea Kattah; Joseph P Grande; Vesna Garovic
Journal:  Am J Kidney Dis       Date:  2018-08-16       Impact factor: 8.860

Review 6.  Liver disease in pregnancy and fetal fatty acid oxidation defects.

Authors:  J A Ibdah; Z Yang; M J Bennett
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

Review 7.  Chronic renal disease in pregnancy.

Authors:  Susan M Ramin; Alex C Vidaeff; Edward R Yeomans; Larry C Gilstrap
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

8.  Changing picture of acute kidney injury in pregnancy: Study of 259 cases over a period of 33 years.

Authors:  J Prakash; P Pant; S Prakash; M Sivasankar; R Vohra; P K Doley; L K Pandey; U Singh
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug

Review 9.  Maternal kidney function during pregnancy: systematic review and meta-analysis.

Authors:  V A Lopes van Balen; T A G van Gansewinkel; S de Haas; J J Spaan; C Ghossein-Doha; S M J van Kuijk; J van Drongelen; T Cornelis; M E A Spaanderman
Journal:  Ultrasound Obstet Gynecol       Date:  2019-08-06       Impact factor: 7.299

10.  MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy.

Authors:  Raul Fernandez-Prado; Sol Maria Carriazo-Julio; Roser Torra; Alberto Ortiz; María Vanessa Perez-Gomez
Journal:  Clin Kidney J       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.